Rv1218c, an ABC transporter of Mycobacterium tuberculosis with implications in drug discovery

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 12, 2010, Pages 5167-5172

  Balganesh, Meenakshi ^a   Kuruppath, Sanjana ^a,b   Marcel, Nimi ^a,c   Sharma, Sreevalli ^a   Nair, Anju ^a   Sharma, Umender ^a  

^a ASTRAZENECA   (United Kingdom)

^b DEAKIN UNIVERSITY   (Australia)

^c TATA INSTITUTE OF FUNDAMENTAL RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER; AZI 219; AZI 224; AZI 335; AZI 336; AZI 371; AZI 524; AZI 530; AZI 531; AZI 532; AZI 533; AZO 521; AZO 530; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CIPROFLOXACIN; ETHAMBUTOL; ETHIDIUM BROMIDE; ISONIAZID; KANAMYCIN; NOVOBIOCIN; PIPERAZINE DERIVATIVE; PYRAZOLONE DERIVATIVE; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; RESERPINE; RIFAMPICIN; STREPTOMYCIN; TETRACYCLINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DEVELOPMENT; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PLASMID; PRIORITY JOURNAL; RV1218C BACTERIAL GENE;

ANTITUBERCULAR AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BACTERIAL PROTEINS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; DRUG DISCOVERY; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PYRAZOLONES; RESERPINE; VERAPAMIL;

EID: 78649642212     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00610-10     Document Type: Article

References (30)

1. Ainsa, J. A., M. C. Blokpoel, I. Otal, D. B. Young, K. A. De Smet, and C. Martin. 1998. Molecular cloning and characterization of Tap, a putative multidrug efflux pump present in Mycobacterium fortuitum and Mycobacterium tuberculosis. J. Bacteriol. 180:5836-5843.
2. Alibert, S., and J-M. Pages. 2007. Efflux pump inhibitors in bacteria. Expert Opin. Ther. Pat. 17:883-888.
3. Bambeke, F. V., J.-M. Pages, and V. J. Lee. 2006. Inhibitors of bacterial efflux pumps as adjuvants in antibiotic treatments and diagnostic tools for detection of resistance by efflux. Recent Pat. Antiinfect. Drug Discov. 1:157-175.
4. Braibant, M., P. Gilot, and J. Content. 2000. The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis. FEMS Microbiol. Rev. 24:449-467.
5. Calver, A. D., A. A. Falmer, M. Murray, O. J. Strauss, E. M. Streicher, M. Hanekom, T. Liversage, M. Masibi, P. D. van Helden, R. M. Warren, and T. C. Victor. 2010. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg. Infect. Dis. 16:264-271.
6. Colangeli, R., D. Helb, S. Sridharan, J. Sun, M. Varma-Basil, M. H. Hazbón, R. Harbacheuski, N. J. Megjugorac, W. R. Jacobs, Jr., A. Holzenburg, J. C. Sacchettini, and D. Alland. 2005. The Mycobacterium tuberculosis iniA gene is essential for activity of an efflux pump that confers drug tolerance to both isoniazid and ethambutol. Mol. Microbiol. 55:1829-1840.
7. Danilchanka, O., C. Mailaender, and M. Niederweis. 2008. Identification of a novel multidrug efflux pump of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 52:2503-2511.
8. Davis, B. D., L. L. Chen, and P. C. Tai. 1986. Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides. Proc. Natl. Acad. Sci. U. S. A. 83:6164-6168.
9. De Rossi, E., J. A. Ainsa, and G. Riccardi. 2006. Role of mycobacterial efflux transporters in drug resistance: an unresolved question. FEMS Microbiol. Rev. 30:36-52.
10. Dye, C., K. Lönnroth, E. Jaramillo, B. G. Williams, and M. Raviglione. 2009. Trends in tuberculosis incidence and their determinants in 134 countries. Bull. World Health Organ. 87:683-691.
11. Gupta, A. K., V. M. Katoch, D. S. Chauhan, R. Sharma, M. Singh, K. Venkatesan, and V. D. Sharma. 2010. Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculosis drugs. Microb. Drug Resist. 16:21-28.
12. Harries, A. D., and C. Dye. 2006. Tuberculosis. Ann. Trop. Med. Parasitol. 100:415-431.
13. Huda, N., E. W. Lee, J. Chen, Y. Morita, T. Kuroda, T. Mizushima, and T. Tsuchiya. 2003. Molecular cloning and characterization of an ABC multi-drug efflux pump, VcaM, in non-O1 Vibrio cholerae. Antimicrob. Agents Chemother. 47:2413-2417. (Pubitemid 36919438)
14. Jiang, X., W. Zhang, Y. Zhang, F. Gao, C. Lu, X. Zhang, and H. Wang. 2008. Assessment of efflux pump gene expression in a clinical isolate Mycobacterium tuberculosis by real-time reverse transcription PCR. Microb. Drug Resist. 14:7-11.
15. Louw, G. E., R. M. Warren, N. C. Gey van Pittius, C. R. E. McEvoy, P. D. Van Helden, and T. C. Victor. 2009. A balancing act: efflux/influx in mycobacterial drug resistance. Antimicrob. Agents Chemother. 53:3181-3189.
16. Marcel, N., A. Nahta, and M. Balganesh. 2008. Evaluation of killing kinetics of anti-tuberculosis drugs on Mycobacterium tuberculosis using a bacteriophage-based assay. Chemotherapy 54:404-411.
17. Nguyen, L., and C. J. Thompson. 2006. Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm. Trends Microbiol. 14:304-312.
18. Nikaido, H. 2001. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria. Semin. Cell Dev. Biol. 12:215-223.
19. Palomino, J. C., A. Martin, M. Camacho, H. Guerra, J. Swings, and F. Portaels. 2002. Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 46:2720-2722.
20. Parish, T., and N. G. Stoker. 2000. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 146:1969-1975.
21. Piddock, L. J. 2006. Multidrug-resistance efflux pumps - not just for resistance. Nat. Rev. Microbiol. 4:629-636.
22. Piddock, L. J. 2006. Clinically relevant chromosomally encoded multidrug resistance efflux pumps in bacteria. Clin. Microbiol. Rev. 19:384-402.
23. Poole, K. 2005. Efflux-mediated antimicrobial resistance. J. Antimicrob. Chemother. 56:20-51.
24. Ramon-Garcia, S., C. Martin, J. A. Ainsa, and E. De Rossi. 2005. Characterisation of tetracycline resistance mediated by the efflux pump Tap from Mycobacterium fortuitum. J. Antimicrob. Chemother. 57:252-259.
25. Ramon-Garcia, S., C. Martin, E. De Rossi, and J. A. Ainsa. 2007. Contribution of the Rv2333c efflux pump (the Stp protein) from Mycobacterium tuberculosis to intrinsic antibiotic resistance in Mycobacterium bovis BCG. J. Antimicrob. Chemother. 59:544-547.
26. Ramon-Garcia, S., C. Martin, C. J. Thompson, and J. A. Ainsa. 2009. Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob. Agents Chemother. 53:3675-3682.
27. Siddiqi, N., R. Das, N. Pathak, S. Banerjee, N. Ahmed, V. M. Katoch, and S. E. Hasnain. 2004. Mycobacterium tuberculosis isolate with a distinct genomic identity overexpresses a tap-like efflux pump. Infection 32:109-111.
28. Stover, C. K., V. F. de la Cruz, T. R. Fuerst, J. E. Burlein, L. A. Benson, L. T. Bennett, G. P. Bansal, J. F. Young, M. H. Lee, G. F. Hatfull, S. B. Snapper, R. G. Barletta, W. R. Jacobs, Jr., and B. R. Bloom. 1991. New use of BCG for recombinant vaccines. Nature 351:456-460.
29. Wards, B. J., and D. M. Collins. 1996. Electroporation at elevated temperatures substantially improves transformation efficiency of slow-growing mycobacteria. FEMS Microbiol. Lett. 145:101-105.
30. Zainuddin, Z. F., and J. W. Dale. 1990. Does Mycobacterium tuberculosis have plasmids? Tubercle 71:43-49.